In-vitro Diagnostics Market By Technology 2018 – 2024 | Top Key Players Thermo Fisher, Siemens, Abbott, Johnson & Johnson, Becton Dickinson, BioRad, BioMerieux, Danaher, Grifols, Luminex, Roche Diagnostics, Sorin, Qiagen

The global in-vitro diagnostics market is estimated to amass substantial proceeds over the ensuing years attributed to the rising pervasiveness of chronic diseases and growing geriatric population across the globe.

According to the 2017 National Population Projections of the United States Census Bureau, the year 2030 will mark a significant turning point in the history of U.S demographics as baby boomers will be over 65 years. This signifies that for the first-time older population will outnumber children in the US. Meanwhile, the median age of the United States population is projected to grow from 38 to 43 years of age by 2060. Health issues being rampant in the old age, the geriatric population will be more susceptible to chronic infections like diarrhea, tuberculosis, and others that will help proliferate the growth of in-vitro diagnostics market.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1230579/

U.S. in-vitro diagnostics market valued at USD 23.9 billion in 2017 and is expected to grow exponentially over the forecast timeframe. According to CDC, around 40% of the Americans expire due to chronic diseases that will enhance industry growth. Moreover, development of favorable reimbursement scenario will drive the business growth significantly.

Technologically advanced countries such as Germany and UK focus their efforts on R&D to manufacture automated laboratory diagnostic machines and equipment for accurate detection of diseases. For instance, companies such as Qaigen headquartered in Germany are leaders in providing point of care molecular diagnostics possessing highest accuracy and the results are displayed on the computers for complete analysis. Assays designed by such companies offer quicker and reliable analysis that will encourage its preference over other conventional methods available. However, high cost associated with the diagnostic procedures will hamper in-vitro diagnostics market growth.

In-vitro diagnostics market should witness considerable growth over the forecast timeframe owing to the growing awareness amongst patients regarding the availability of diagnostic tests. Technology integrated within these devices will improve efficiency of diagnostic devices proving beneficial for the industry growth. Various American organizations such as Center for Chronic Disease Control have implemented certain initiatives that will increase awareness levels for availability of technologically advanced diagnostics among the people that should impact positively in-vitro diagnostics market growth in the upcoming future. In-vitro Diagnostics Market will exceed USD 92 billion by 2024; as per a new research report.

Reagents and kits segment held largest market share of 67.7% in 2017 as a result of high prevalence of rare diseases that will have a positive impact on segmental growth. Escalating usage of molecular reagents for detection of various diseases such as Morgellons, Adie syndrome and Crohn disease will boost industry growth over the forecast timeframe. Moreover, key industry players such as Bio-Rad, Beckman Coulter and Cambio emphasize on manufacturing superior quality reagents that aid accurate diagnosis thereby, fosters in-vitro diagnostics industry growth over the forecast timeframe.

Molecular diagnostics segment accounted for 16.2% revenue share in 2017 and growth can be accounted to high cases of diabetes and other chronic infections that demand critical monitoring. According to International Diabetes Federation in 2017, there were around 7.4 million cases of diabetes in Germany that will increase the demand in upcoming years.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1230579/

Oncology segment held USD 12.6 billion in 2017 as a result of rising cases of cancer globally. Additionally, growing prevalence of cancer in developing countries such as India will increase the demand for molecular diagnostic reagents and devices. In India, there are around 1.4 million cases of cancer every year that will boost segmental growth over the forecast timeframe.

Hospitals segment of in-vitro diagnostics market held largest revenue share of 30.6% and should expand significantly in the coming years due to increasing number of hospital admissions demanding critical monitoring and accurate diagnosis. According to Statista hospital care expenditures in 2017, was around USD 1,132.6 billion in the U.S. indicating strong demand for in-vitro diagnostics in the upcoming years.

Some of the prominent industry players operating in in-vitro diagnostics industry is Abbott, Becton Dickinson, BioRad, BioMerieux, Cephied, Danaher, Grifols, Johnson & Johnson, Luminex, Roche Diagnostics, Siemens, Sorin, Thermo Fisher and Qiagen. Strategic initiatives such as new product launch, mergers & acquisition will aid revenue generation for the company. For instance, in April 2017, Abbott declared acquisition of Alere that has enabled Abbott?s point-of-care testing product portfolio that will help Abbott to maintain its market position.

Table of Content:

Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. In-vitro diagnostics industry 360 degree synopsis, 2013 - 2024

2.1.1. Business trends

2.1.2. Type trends

2.1.3. Technology trends

2.1.4. Application trends

2.1.5. End-user trends

2.1.6. Regional trends

Chapter 3. In-vitro Diagnostics Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Growing rate of healthcare infections particularly in North America

3.3.1.2. Increasing adoption rate of automated diagnostic machine & equipment in Europe

3.3.1.3. Rising geriatric population preferring personalized medicines in Asia Pacific

3.3.1.4. Surging number of pathology labs and services equipped with advanced diagnostics machine

3.3.1.5. Increasing awareness regarding viral disease detection in the U.S.

3.3.2. Industry pitfalls and challenges

3.3.2.1. Excessive cost of diagnosis service

3.4. Growth potential analysis

3.4.1. By type

3.4.2. By technology

3.4.3. By application

3.4.4. By end-user

3.5. Regulatory landscape

3.5.1. U.S.

3.5.2. Europe

3.6. Porter's analysis

3.7. Competitive landscape, 2017

3.7.1. Strategy dashboard

3.8. PESTEL analysis

Chapter 4. In-vitro Diagnostics Market, By Type

4.1. Key segment trends

4.2. Product

4.2.1. Market size, by region, 2013-2024 (USD Million)

4.2.2. Reagents & kits

4.2.2.1. Market size, by region, 2013-2024 (USD Million)

4.2.3. Instruments

4.2.3.1. Market size, by region, 2013-2024 (USD Million)

4.3. Service

4.3.1. Market size, by region, 2013-2024 (USD Million)

4.3.2. Software

4.3.2.1. Market size, by region, 2013-2024 (USD Million)

4.3.3. Testing services

4.3.3.1. Market size, by region, 2013-2024 (USD Million)

Chapter 5. In-vitro Diagnostics Market, By Technology

Outer scope of this report back in 2014, Rheonix, a company that specializes in the production of automated molecular testing solutions, exhibited the ‘the future of in-vitro diagnostics’ at a conference held by Siemens Venture Capital. Rhoenix’s products proved to fully automate the molecular analysis of an extensive set of samples, like tissues, swabs or blood for medical analyses ranging from infectious diseases to oncology. The company’s core product was a microfluidic device known as the Rheonix CARD. The company’s products tend to simplify the overall molecular diagnostic testing process by abolishing the requirement for several equipment, reducing investigation time and increasing cost-effectiveness while eliminating the risk of human error.

Therefore, manufacturers technologically enhancing their diagnostic devices will boost product adoption, thereby aiding the in-vitro diagnostics market growth over the coming years.

For more information on this report at: https://www.marketstudyreport.com/reports/in-vitro-diagnostics-market/?utm_source=Openpr.com-SP

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email:sales@marketstudyreport.com
Website:https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/

This release was published on openPR.